0001181431-12-060932.txt : 20121128 0001181431-12-060932.hdr.sgml : 20121128 20121128193550 ACCESSION NUMBER: 0001181431-12-060932 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20121126 FILED AS OF DATE: 20121128 DATE AS OF CHANGE: 20121128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ANDO DALE G CENTRAL INDEX KEY: 0001202278 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30171 FILM NUMBER: 121230137 MAIL ADDRESS: STREET 1: C/O CELL GENESYS INC STREET 2: 500 FORBES BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SANGAMO BIOSCIENCES INC CENTRAL INDEX KEY: 0001001233 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 680359556 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: POINT RICHMOND TECH CNTR. CITY: RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: 5109706000 MAIL ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: POINT RICHMOND TECH CNTR. CITY: RICHMOND STATE: CA ZIP: 94804 4 1 rrd361677.xml X0306 4 2012-11-26 0 0001001233 SANGAMO BIOSCIENCES INC SGMO 0001202278 ANDO DALE G C/O SANGAMO BIOSCIENCES INC. POINT RICHMOND TECH CNTR, 501 CANAL BLVD RICHMOND CA 94804 0 1 0 0 VP, Therapeutic Dev. & CMO Common Stock 2012-11-26 4 S 0 4736 5.3278 D 55798 D Common Stock 2012-11-27 4 M 0 15000 3.61 A 70798 D Common Stock 2012-11-27 4 S 0 15000 5.600 D 55798 D Employee Stock Option (Right to Buy) 3.61 2012-11-27 4 M 0 15000 0.00 D 2014-08-01 15000 0 50800 D The sales resported in this Form 4 were effected pursauant to the Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2012, amended on September 12, 2012. The price reported in Column 4 is a weighted average price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.31 to #53501, inclusive. The Reporting person undertakes to provide to Sangamo Biosciences Inc., any security holder of separate price within the manages set forth in footnotes (2) and (3) to this Form 4. Includes 2,000 shares acquired by Reporting Person on October 31, 2012 under the Issuer's Employee Stock Purchase Plan. All shares underlying this option are vested and immediatedly exercisalbe. Exhibit list Exhibit 24 - Power of Attorney /s/ Florence Tam, attorney-in-fact 2012-11-27 EX-24. 2 rrd324601_366898.htm POWER OF ATTORNEY rrd324601_366898.html 
                                  POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes and
appoints Florence Tam with full power of substitution, the undersigned's true
and lawful attorney-in-fact to:


1. execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer or director, as the case may be, of Sangamo Biosciences Inc.
(the "Company"), Forms 3, 4 and 5 (and any amendments
thereto) in accordance with Section 16(a) of the Securities Exchange Act of
1934, as amended (the "Exchange Act"), and the rules thereunder;


2. do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3, 4 or 5,
complete and execute any amendments thereto, and timely file such form with the
U.S. Securities and Exchange Commission (the "SEC") and any securities exchange
or similar authority,
including without limitation the filing of a Form ID or any other documents
necessary or appropriate to enable the undersigned to file the Forms 3, 4 and
5 electronically with the SEC; and


3. seek or obtain, as the undersigned's representative and on the undersigned's
behalf, information on transactions in the Company's securities from any broker
or financial institution, and the undersigned hereby authorizes any such person
to release any such information to each of the undersigned's attorneys-in-fact
appointed by this Power of Attorney and approves and ratifies any such release
of information; and


4. take any other action in connection with the foregoing which, in the opinion
of such attorney-in-fact, may be of benefit to, in the best interest of, or
legally required by or for, the undersigned, it being understood that the
documents executed by such attorney-in-fact on behalf of the undersigned
pursuant to this  Power of Attorney shall be in such form and shall contain
such information and disclosure as such attorney-in-fact may approve in such
attorney-in-fact's discretion.


The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever required,
necessary or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might
or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such attorney-in-fact,
or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause
to be done by virtue of this Power of Attorney and
the rights and powers herein granted.


The undersigned acknowledges that the foregoing attorneys-in-fact, in serving
in such capacity at the request and on the behalf of the undersigned, are not
assuming, nor is the Company assuming, any of the undersigned's responsibilities
to comply with, or any liability for the failure to comply with, any provision
of Section 16 of the Exchange Act.


This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 or 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to each
of the foregoing attorneys-in-fact.


IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney as of
this 27th day of November, 2012.


Signed and acknowledged:

/s/ Dale Ando
------------------------------
Signature

By:  Dale Ando